Free Trial
NASDAQ:NTBL

Notable Labs (NTBL) Stock Price, News & Analysis

$0.74
+0.00 (+0.38%)
(As of 10:01 AM ET)
Today's Range
$0.73
$0.74
50-Day Range
$0.52
$1.48
52-Week Range
$0.51
$10.84
Volume
3,027 shs
Average Volume
287,852 shs
Market Capitalization
$6.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Notable Labs MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
853.0% Upside
$7.00 Price Target
Short Interest
Bearish
5.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of Notable Labs in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.81 out of 5 stars

NTBL stock logo

About Notable Labs Stock (NASDAQ:NTBL)

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

NTBL Stock Price History

NTBL Stock News Headlines

Human testing is the last step before this company goes big
Biotech innovations have the potential to change the world. And help you build wealth in the process.
Notable Labs: Q1 Earnings Snapshot
NTBL Notable Labs, Ltd.
Human testing is the last step before this company goes big
Biotech innovations have the potential to change the world. And help you build wealth in the process.
See More Headlines
Receive NTBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Notable Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/16/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NTBL
Previous Symbol
NASDAQ:NTBL
Employees
16
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$9.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+853.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-11,260,000.00
Pretax Margin
-2,816.08%

Debt

Sales & Book Value

Annual Sales
$310,000.00
Book Value
$6.81 per share

Miscellaneous

Free Float
8,910,000
Market Cap
$6.63 million
Optionable
No Data
Beta
1.00
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Thomas A. Bock M.B.A. (Age 59)
    M.D., CEO & Director
    Comp: $508.82k
  • Mr. Scott Alan McPherson CFE (Age 63)
    CPA, CVA, Chief Financial Officer
    Comp: $412.89k
  • Dr. Joseph P. Wagner Ph.D. (Age 56)
    Chief Scientific Officer
    Comp: $424.88k
  • Dr. Glenn C. Michelson M.D.
    Chief Medical Officer

NTBL Stock Analysis - Frequently Asked Questions

How have NTBL shares performed this year?

Notable Labs' stock was trading at $1.89 at the beginning of the year. Since then, NTBL stock has decreased by 61.1% and is now trading at $0.7345.
View the best growth stocks for 2024 here
.

How were Notable Labs' earnings last quarter?

Notable Labs, Ltd. (NASDAQ:NTBL) posted its earnings results on Wednesday, May, 15th. The company reported ($0.42) EPS for the quarter.

How do I buy shares of Notable Labs?

Shares of NTBL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTBL) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners